Abacus Planning Group, Inc. Merck & Co., Inc. Transaction History

Abacus Planning Group, Inc.

$552 Million
Q1 2025

A detailed history of Abacus Planning Group, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Abacus Planning Group, Inc. holds 14,335 shares of MRK stock, worth $1.11 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares

14,335

Previous 12,025 19.21%

Holding current value

$1.11 Million

Previous $1.2 Million 7.53%

% of portfolio

0.23%

Previous 0.22%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 14, 2025	BUY	$83.01 - $101.02 $191,753 - $233,356	2,310 Added 19.21%	14,335 $1.29 Million
Q4 2024 Jan 31, 2025	BUY	$96.31 - $114.76 $4,526 - $5,393	47 Added 0.39%	12,025 $1.2 Million
Q3 2024 Oct 02, 2024	SELL	$111.15 - $128.97 $21,785 - $25,278	-196 Reduced 1.61%	11,978 $1.36 Million
Q2 2024 Jul 30, 2024	BUY	$123.8 - $132.96 $138,160 - $148,383	1,116 Added 10.09%	12,174 $1.51 Million
Q1 2024 Apr 11, 2024	SELL	$113.24 - $131.95 $55,374 - $64,523	-489 Reduced 4.23%	11,058 $1.46 Million
Q4 2023 Jan 19, 2024	SELL	$100.18 - $109.02 $54,497 - $59,306	-544 Reduced 4.5%	11,547 $1.26 Million
Q3 2023 Oct 11, 2023	SELL	$102.95 - $114.33 $96,464 - $107,127	-937 Reduced 7.19%	12,091 $1.24 Million
Q2 2023 Jul 06, 2023	BUY	$108.61 - $118.38 $109,044 - $118,853	1,004 Added 8.35%	13,028 $1.5 Million
Q1 2023 Apr 17, 2023	SELL	$102.94 - $114.86 $23,882 - $26,647	-232 Reduced 1.89%	12,024 $1.28 Million
Q4 2022 Jan 19, 2023	BUY	$87.44 - $112.11 $89,101 - $114,240	1,019 Added 9.07%	12,256 $0
Q3 2022 Oct 18, 2022	SELL	$84.53 - $94.96 $163,142 - $183,272	-1,930 Reduced 14.66%	11,237 $968,000
Q2 2022 Jul 18, 2022	SELL	$83.49 - $94.64 $72,803 - $82,526	-872 Reduced 6.21%	13,167 $1.2 Million
Q1 2022 Apr 13, 2022	SELL	$73.51 - $82.4 $9,997 - $11,206	-136 Reduced 0.96%	14,039 $1.15 Million
Q4 2021 Jan 18, 2022	BUY	$72.28 - $90.54 $148,390 - $185,878	2,053 Added 16.94%	14,175 $1.09 Million
Q3 2021 Oct 19, 2021	BUY	$71.68 - $78.83 $12,902 - $14,189	180 Added 1.51%	12,122 $910,000
Q2 2021 Jul 20, 2021	SELL	$70.31 - $77.77 $11,038 - $12,209	-157 Reduced 1.3%	11,942 $929,000
Q1 2021 Apr 27, 2021	BUY	$68.86 - $81.11 $13,083 - $15,410	190 Added 1.6%	12,099 $933,000
Q4 2020 Feb 01, 2021	SELL	$71.77 - $79.65 $11,483 - $12,744	-160 Reduced 1.33%	11,909 $974,000
Q3 2020 Nov 03, 2020	SELL	$73.18 - $82.95 $36,150 - $40,977	-494 Reduced 3.93%	12,069 $1 Million
Q2 2020 Aug 11, 2020	BUY	$70.42 - $80.13 $18,027 - $20,513	256 Added 2.08%	12,563 $971,000
Q1 2020 Apr 30, 2020	BUY	$63.36 - $87.82 $9,884 - $13,699	156 Added 1.28%	12,307 $947,000
Q4 2019 Jan 30, 2020	SELL	$77.58 - $87.54 $31,342 - $35,366	-404 Reduced 3.22%	12,151 $1.11 Million
Q3 2019 Nov 01, 2019	BUY	$76.08 - $82.93 $195,906 - $213,544	2,575 Added 25.8%	12,555 $1.06 Million
Q1 2019 Apr 25, 2019	SELL	$69.58 - $79.36 $9,393 - $10,713	-135 Reduced 1.33%	9,980 $830,000
Q4 2018 Feb 15, 2019	SELL	$65.24 - $75.71 $767,809 - $891,030	-11,769 Reduced 53.78%	10,115 $773,000
Q4 2018 Feb 14, 2019	BUY	$65.24 - $75.71 $1.43 Million - $1.66 Million	21,884 New	21,884 $3.13 Million

Others Institutions Holding MRK

# of Institutions

3,891

Shares Held

1.93B

Call Options Held

26.2M

Put Options Held

23.5M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $197B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Abacus Planning Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Abacus Planning Group, Inc. with notifications on news.

Account

Abacus Planning Group, Inc. Merck & Co., Inc. Transaction History